Literature DB >> 9086159

Detection of infection with human immunodeficiency virus type 1 before seroconversion: correlation with clinical symptoms and outcome.

J P Phair1, J B Margolick, L P Jacobson, J Phillips, C Rinaldo, R Kaslow, C Chu, J V Giorgi, D Henrard.   

Abstract

Early (pre-seroconversion) infection with human immunodeficiency virus type 1 (HIV-1) was identified in 50 of 267 participants in the Multicenter AIDS Cohort Study. These 50 men had a positive EIA result, which detected IgM antibody (n = 35), p24 antigen, or serum HIV RNA (n = 15) at their last "seronegative" visit. At that visit, the mean CD4 lymphocyte number (890/mm3 vs. 1038/mm3) was significantly lower than in men who subsequently seroconverted but had no evidence of early infection. The decline in CD4 cells was slower and the duration of AIDS-free time longer in the 19 men who were symptomatic in comparison to the 31 asymptomatic men with early infection, but differences were not significant.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9086159     DOI: 10.1086/514000

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa.

Authors:  Alethea W McCormick; Nadia N Abuelezam; Erin R Rhode; Taige Hou; Rochelle P Walensky; Pamela P Pei; Jessica E Becker; Madeline A DiLorenzo; Elena Losina; Kenneth A Freedberg; Marc Lipsitch; George R Seage
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

2.  A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection.

Authors:  Joseph B Margolick; Linda Apuzzo; Joel Singer; Hubert Wong; Terry Lee; Joel E Gallant; Phillippe El-Helou; Mona R Loutfy; Anita Rachlis; Christopher Fraser; Kenneth Kasper; Cécile Tremblay; Harout Tossonian; Brian Conway
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.